Category:Nirmatrelvir
chemical compound | |||||
Upload media | |||||
Instance of |
| ||||
---|---|---|---|---|---|
Subclass of | |||||
Mass |
| ||||
| |||||
- INN (International Non-proprietary Name): nirmatrelvir
- Pfizer ID: PF-07321332
- Pfizer trade name: Paxlovid (drug combination: nirmatrelvir / ritonavir)
English: nirmatrelvir (PF-07321332), a SARS-CoV-2-3CL inhibitor, a protease inhibitor developed by Pfizer, used in the combination drug Paxlovid, a combination of nirmatrelvir and ritonavir. An oral antiviral therapeutic drug countering SARS-CoV-2 that causes COVID-19
Media in category "Nirmatrelvir"
The following 8 files are in this category, out of 8 total.
-
Nirmatrelvir Dots.png 4,274 × 4,311; 684 KB
-
Nirtalmatrelvir on 3CL.png 475 × 525; 146 KB
-
PF-07321332 str.svg 228 × 199; 20 KB
-
PF-07321332 structure.png 985 × 841; 41 KB
-
PF-07321332 structure.svg 250 × 215; 53 KB
-
PF-07321332 synthesis.svg 512 × 274; 25 KB
-
PF-07321332.svg 512 × 290; 7 KB
-
Xray crystal structure PDB-7si9.png 1,280 × 980; 394 KB